FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lorraine Soisson

Research Profile

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Living Beings

Aotus trivirgatus

Co-author Network

Publications

TOP 3
Amed Ouattara; SAYE Renion; Lorraine Soisson; Shannon Takala-Harrison; Mahamadou A Thera; Youssouf Tolo; Johan Vekemans; William C Blackwelder; Joe Cohen; Drissa Coulibaly; Carter L Diggs; Ogobara K Doumbo; Tina Dube; Sheetij Dutta; Donald Heppner; Matthew B Laurens; Amadou Niangaly; Christopher Plowe
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
Nekoye Otsyula; Mark E Polhemus; Nancy Richie; Meng Shi; Lorraine Soisson; Donna Tosh; John N Waitumbi; Lisa Ware; Ben Andagalu; Evelina Angov; W Ripley Ballou; Jason Bennett; Elke Bergmann-Leitner; Joe Cohen; James Cummings; Carter L Diggs; Marie-Claude Dubois; Olivier Godeaux; DONALD HEPPNER; Brent House; Farhat Khan; Margaret Koech; Lori Miller; Christian F Ockenhouse; Bernhards R Ogutu; Godfrey Allan Otieno; Lucas Otieno; Walter Otieno; Michele D Spring
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Sheetij Dutta; JoAnn S Sullivan; Katharine K Grady; J David Haynes; Jack Komisar; Adrian H Batchelor; Lorraine Soisson; Carter L Diggs; Donald Heppner; David Lanar; William E Collins; John W Barnwell
High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lorraine Soisson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amed Ouattara; SAYE Renion; Lorraine Soisson; Shannon Takala-Harrison; Mahamadou A Thera; Youssouf Tolo; Johan Vekemans; William C Blackwelder; Joe Cohen; Drissa Coulibaly; Carter L Diggs; Ogobara K Doumbo; Tina Dube; Sheetij Dutta; Donald Heppner; Matthew B Laurens; Amadou Niangaly; Christopher Plowe
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
The Journal of infectious diseases 2013;207(3):511-9.
2013: Nekoye Otsyula; Mark E Polhemus; Nancy Richie; Meng Shi; Lorraine Soisson; Donna Tosh; John N Waitumbi; Lisa Ware; Ben Andagalu; Evelina Angov; W Ripley Ballou; Jason Bennett; Elke Bergmann-Leitner; Joe Cohen; James Cummings; Carter L Diggs; Marie-Claude Dubois; Olivier Godeaux; DONALD HEPPNER; Brent House; Farhat Khan; Margaret Koech; Lori Miller; Christian F Ockenhouse; Bernhards R Ogutu; Godfrey Allan Otieno; Lucas Otieno; Walter Otieno; Michele D Spring
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Malaria journal 2013;12(1):29.
2009: Sheetij Dutta; JoAnn S Sullivan; Katharine K Grady; J David Haynes; Jack Komisar; Adrian H Batchelor; Lorraine Soisson; Carter L Diggs; Donald Heppner; David Lanar; William E Collins; John W Barnwell
High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
PloS one 2009;4(12):e8138.
2007: Mark E Polhemus; Alan J Magill; James F Cummings; Kent Kester; Christian F Ockenhouse; David Lanar; Sheetij Dutta; Arnoldo Barbosa; Lorraine Soisson; Carter L Diggs; Sally A Robinson; J David Haynes; V Ann Stewart; Lisa A Ware; Clara Brando; Urszula Krzych; Robert A Bowden; Joe D Cohen; Marie-Claude Dubois; Opokua Ofori-Anyinam; Els De-Kock; W Ripley Ballou; Donald Heppner
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Vaccine 2007;25(21):4203-12.
2007: Jose Stoute; Joash Gombe; Mark R Withers; Joram Siangla; Denise McKinney; Melanie Onyango; James F Cummings; Jessica Milman; Kathryn Tucker; Lorraine Soisson; V Ann Stewart; Jeffrey A Lyon; Evelina Angov; Amanda Leach; Joe Cohen; Kent Kester; Christian F Ockenhouse; Carolyn A Holland; Carter L Diggs; Janet Wittes; Donald Heppner
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
Vaccine 2007;25(1):176-84.
2006: Christian F Ockenhouse; Evelina Angov; Kent Kester; Carter L Diggs; Lorraine Soisson; James F Cummings; Ann V Stewart; Dupeh R Palmer; Babita Mahajan; Urszula Krzych; Nadia Tornieporth; Martine Delchambre; M Vanhandenhove; Opokua Ofori-Anyinam; Joe Cohen; Jeffrey A Lyon; Donald Heppner
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
Vaccine 2006;24(15):3009-17.
2006: Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Issaka Sagara; Alassane Dicko; David J Diemert; Donald Heppner; V Ann Stewart; Evelina Angov; Lorraine Soisson; Amanda Leach; Kathryn Tucker; Kirsten E Lyke; Christopher Plowe
Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
PLoS clinical trials 2006;1(7):e34.
2006: Mark R Withers; Denise McKinney; Bernhards R Ogutu; John N Waitumbi; Jessica Milman; Odika J Apollo; Otieno G Allen; Kathryn Tucker; Lorraine Soisson; Carter L Diggs; Amanda Leach; Janet Wittes; Filip Dubovsky; V Ann Stewart; Shon A Remich; Joe Cohen; W Ripley Ballou; Carolyn A Holland; Jeffrey A Lyon; Evelina Angov; Jose Stoute; Samuel K Martin; Donald Heppner
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
PLoS clinical trials 2006;1(7):e32.